ArticleJournal of Cancer2020

Carbonic Anhydrase 4 serves as a Clinicopathological Biomarker for Outcomes and Immune Infiltration in Renal Cell Carcinoma, Lower Grade Glioma, Lung Adenocarcinoma and Uveal Melanoma.

Yue Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.